Abstract:It is now clear that major malignancies are heterogeneous diseases associated with diverse molecular properties and clinical outcomes, posing a great challenge for more individualized therapy. In the last decade, cancer molecular subtyping studies were mostly based on transcriptomic profiles, ignoring heterogeneity at other (epi-)genetic levels of gene regulation. Integrating multiple types of (epi)genomic data generates a more comprehensive landscape of biological processes, providing an opportunity to better dissect cancer heterogeneity. Here, we propose sparse canonical correlation analysis for cancer classification (SCCA-CC), which projects each type of single-omics data onto a unified space for data fusion, followed by clustering and classification analysis. Without loss of generality, as case studies, we integrated two types of omics data, mRNA and miRNA profiles, for molecular classification of ovarian cancer ( n = 462), and breast cancer ( n = 451). The two types of omics data were projected onto a unified space using SCCA, followed by data fusion to identify cancer subtypes. The subtypes we identified recapitulated subtypes previously recognized by other groups (all P - values < 0.001), but display more significant clinical associations. Especially in ovarian cancer, the four subtypes we identified were significantly associated with overall survival, while the taxonomy previously established by TCGA did not ( P- values: 0.039 vs. 0.12). The multi-omics classifiers we established can not only classify individual types of data but also demonstrated higher accuracies on the fused data. Compared with iCluster, SCCA-CC demonstrated its superiority by identifying subtypes of higher coherence, clinical relevance, and time efficiency. In conclusion, we developed an integrated bioinformatic framework SCCA-CC for cancer molecular subtyping. Using two case studies in breast and ovarian cancer, we demonstrated its effectiveness in identifying biologically meaningful and clinically relevant subtypes. SCCA-CC presented a unique advantage in its ability to classify both single-omics data and multi-omics data, which significantly extends the applicability to various data types, and making more efficient use of published omics resources.

An omics-to-omics joint knowledge association subtensor model for radiogenomics cross-modal modules from genomics and ultrasonic images of breast cancers

IMAGGS: a radiogenomic framework for identifying multi-way associations in breast cancer subtypes

A unified computational model for revealing and predicting subtle subtypes of cancers

Methods for Joint Imaging and RNA-seq Data Analysis

A Network Embedding Based Method for Partial Multi-Omics Integration in Cancer Subtyping

Multi-Omics Data Fusion via a Joint Kernel Learning Model for Cancer Subtype Discovery and Essential Gene Identification

Multivariate Sparse Group Lasso Joint Model for Radiogenomics Data

Multicenter Radio-Multiomic Analysis for Predicting Breast Cancer Outcome and Unravelling Imaging-Biological Connection

Integrative analysis of pathological images and multi-dimensional genomic data for early-stage cancer prognosis.

Molecular Subtyping of Cancer Based on Distinguishing Co-Expression Modules and Machine Learning

Artificial Intelligence-Based Multi-Omics Analysis Fuels Cancer Precision Medicine.

A Cancer Gene Module Mining Method Based on Bio-Network of Multi-Omics Gene Groups

Association of CT-based Imaging Features and Genomic Data in Non-small Cell Lung Cancer

Deep Radiotranscriptomics of Non-Small Cell Lung Carcinoma for Assessing Molecular and Histology Subtypes with a Data-Driven Analysis

Discovering and interpreting transcriptomic drivers of imaging traits using neural networks

Functional Analysis of Molecular Subtypes with Deep Similarity Learning Model Based on Multi-omics Data

Multi-Omics Data Fusion for Cancer Molecular Subtyping Using Sparse Canonical Correlation Analysis

Integrated imaging and molecular analysis to decipher tumor microenvironment in the era of immunotherapy

Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets

BioSTD: A New Tensor Multi-View Framework Via Combining Tensor Decomposition and Strong Complementarity Constraint for Analyzing Cancer Omics Data.

Multi-level Knowledge Integration with Graph Convolutional Network for Cancer Molecular Subtype Classification